F. Bellutti Enders

Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation

S. Kamphuis, P. H. Hissink Muller, E. Hoppenreijs, 2019, Arthritis & rheumatology.

Improving the Translational Medicine Process: Moving Patients From “End-Users” to “Engaged Collaborators”

N. Wulffraat, M. Battaglia, P. Furlong, 2019, Front. Med..

Increased Presence of FOXP3+ Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood

V. Ricotti, L. Wedderburn, B. Prakken, 2014, PloS one.

Correlation of CXCL10, Tumor Necrosis Factor Receptor Type II, and Galectin 9 With Disease Activity in Juvenile Dermatomyositis

B. Prakken, F. Wijk, M. Hofer, 2014, Arthritis & rheumatology.

Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells

G. Pantaleo, M. Cavassini, I. Miconnet, 2013, PLoS pathogens.

[Transient hypogammaglobulinemia of infancy].

F. Candotti, F. Angelini, F. Conti, 2020, Revue medicale suisse.

Immune deficiency, autoimmune disease and intellectual disability: A pleiotropic disorder caused by biallelic variants in the TPP2 gene

C. Rivolta, F. Candotti, A. Bottani, 2021, Clinical genetics.